PCA
NTUS

Peddock Capital Advisors’s Natus Medical Inc NTUS Stock Holding History

Peddock Capital Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-539
Closed -$18K – 271
2018
Q1 		$18K Hold
539
– – 0.01% 208
2017
Q4 		$21K Hold
539
– – 0.01% 202
2017
Q3 		$20K Hold
539
– – 0.01% 205
2017
Q2 		$20K Hold
539
– – 0.01% 204
2017
Q1 		$21K Buy
+539
New +$20.2K 0.01% 182

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Peddock Capital Advisors's NTUS Position: Q2 2018 in Review

Peddock Capital Advisors sold out of Natus Medical Inc (NTUS) in Q2 2018, closing a stake of 539 shares — an estimated $18K sold.

Peddock Capital Advisors first reported a position in NTUS in Q1 2017 and held it in 5 quarters. The position peaked at $21K in Q4 2017. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2018.

  • Peddock Capital Advisors reported no remaining Natus Medical Inc position as of Q2 2018 after selling out during the quarter.
  • Peddock Capital Advisors sold 539 Natus Medical Inc shares in Q2 2018, an estimated $18K.
  • Peddock Capital Advisors first reported a position in Natus Medical Inc in Q1 2017 and held it in 5 quarters.
  • Peddock Capital Advisors's Natus Medical Inc position peaked at $21K in Q4 2017.
  • 175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2018.

Based on Peddock Capital Advisors's 13F filing for Q2 2018, filed 3 Aug 2018.